Gemcitabine/Cisplatin +/- Sorafenib for the First-Line Treatment of Chemonaive Chinese Patients with Advanced, Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Subgroup Analysis of the Phase III NExUS Trial
JOURNAL OF THORACIC ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要